Linezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus
Linezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus
To determine if linezolid is superior to vancomycin in the treatment of nosocomial (acquired in the hospital) pneumonia due to Methicillin Resistant Staphylococcus Aureus (MRSA) in adult subjects. Subjects entered in to the study will have proven healthcare-associated methicillin-resistant Staphylococcus aureus pneumonia which will be treated with either linezolid or vancomycin.
Inclusion Criteria:
Exclusion Criteria:
Jackson, Florida 32209, United States
Saint Loius, Missouri 63110, United States
Sequin, Texas 78155, United States
Buenos Aires, Buenos Aires 1181, Argentina
Bogota, Cundinamarca, Colombia
Crete, Greece 71110, Greece
Monterrey/Col. Mitras Centro, Nuevo Léon 64460, Mexico
Bloefontein, 9301, South Africa